Achillion Gets Another Bump (ACHN)

Posted in pre-market 
December 23rd, 2009

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) is trading higher after its $3.18 close on Tuesday.   At 8:50 AM EST we have shares trading up 21% at $3.85 on over 330,000 shares in pore-market trading.  A boutique brokerage firm called Roth Capital initiated coverage with a BUY rating and a $12 target.  Achillion has been one of the small cap and low-priced stocks in biotech being chased around as traders look and hope for the next ten-bagger.  The 52-week trading range is $0.65 to $3.89 and the average volume is only about 220,000 shares.


Comments are closed